Haemonetics Corporation

Healthcare · Medical Devices

108.40$ +0.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 1,334 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement HAE
Line item	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Revenue	310	286	282	278	294	320	337	364	384	420	450	516	598	645	677	728	892	939	910	909	886	904	968	988	870	993	1,169	1,309	1,361	1,334
Cost of Revenue	138	127	124	122	127	165	182	192	186	199	222	259	290	308	321	359	464	470	476	503	508	492	550	501	442	462	546	597	582	590
Gross Profit	172	159	158	156	167	155	155	172	198	221	227	258	308	337	355	369	428	468	434	406	378	412	418	488	428	531	623	712	779	744
Research & Development	19	18	15	15	19	20	20	18	20	27	24	24	24	26	33	37	49	54	54	56	47	39	36	39	41	55	59	63	69	60
Selling, General & Administrative	92	87	87	83	87	89	98	109	118	121	137	163	199	215	206	245	314	365	259	313	299	313	294	262	261	328	367	414	414	442
Total Operating Expenses	124	128	126	123	110	108	117	126	138	122	155	187	223	241	245	282	367	421	394	450	398	356	334	384	339	450	467	547	557	502
Operating Income	48	31	32	34	13	36	37	46	60	99	63	70	86	83	111	89	56	47	41	-44	-19	56	84	103	90	81	156	165	222	241
Interest Expense	6.3	75	5.9	13	59	14	3.5	0.9	0.0	37	0.1	9.0	0.1	0.7	0.0	55	6.5	11	9.4	9.5	8.1	4.5	9.9	16	17	17	15	13	9.7	29
Pre-Tax Income	51	4.5	33	27	17	39	39	46	60	107	72	77	85	81	110	89	50	36	31	-53	-27	60	74	87	73	64	141	152	212	128
Income Tax Expense	18	3.9	11	8.5	10	11	10	16	20	38	23	25	26	23	30	23	11	1.3	14	2.2	-1.2	14	19	11	-6.6	20	26	34	44	31
Net Income	33	-25	21	19	7.2	30	28	29	40	69	49	52	59	58	80	67	39	35	17	-56	-26	46	55	77	79	43	115	118	168	97
EBITDA	72	54	51	73	81	72	66	77	88	124	101	101	122	125	158	139	125	129	127	129	123	153	193	258	184	192	252	295	356	312

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings